peripheral vascular disease · 2015-07-07 · 전남대학교병원순환기내과 김계훈...
TRANSCRIPT
전남대학교병원 순환기내과
김 계 훈
Peripheral Vascular Disease
혈관연구회 연수강좌 - 2007
CC Cramping pain in left calf at walking (D: 6 Mo)
PH HT, DM: medication for 10 years
SH Smoking : 50 PYs, Current smoker
PI Progressively worsened over the past 6 months
Interfering with his ability to perform his job
Should rest after walking half a block
Case 1: 서 O O (69/M)
병력상 이 환자에서 가장 의심되는 질환은?
1) Spinal stenosis
2) Peripheral vascular disease of the lower extremity
3) Compartment syndrome
4) Arthritis
Case 1: 서 O O (69/M)
D/D of Claudication from Pseudoclaudication
VS BP 150/95 mmHg PR 92/min
BT 36.4℃ RR 20/min
PE Bruit on left inguinal area
Right Left
Brachial & radial pulse Normal Normal
Femoral pulse Normal Decreased
Popliteal pulse Decreased Decreased
Dorsalis pulse Decreased Absent
Case 1: 서 O O (69/M)
Lab findings CBC: WNL LFT & RFS: WNL
UA: microalbuminuria (+)
Lipid profiles
TC: 256 mg/dL
TG: 210 mg/dL
HDLC: 38 mg/dL
LDLC: 180 mg/dL
Case 1: 서 O O (69/M)
▶ Broadly encompasses the vascular diseases
▶ Caused primarily by atherosclerosis and thromboembolic
pathophysiologic processes
▶ Alter the normal structure and function of the aorta, its visceral
branches, and the arteries of the lower extremities
▶ Denote stenotic, occlusive, and aneurysmal diseases of the aorta
and its branch arteries, exclusive of the coronary arteries
Definition of PAD
ACC/AHA guideline 2005. JACC 2006
Natural History of PAD
Diagnostic Workup
• Carefully history taking
• D/D from pseudoclaudication
Examined with shoes
and socks off
With attention to pulses,
hair loss, skin color,
trophic skin changes
이 환자의 진단을 위해 시행할 initial screening test로 적절한 것은?
1) Lumbar CT or MRI
2) Duplex ultrasound
3) CT angiography of the lower extremities
4) Ankle-brachial index (ABI)
Diagnostic Workup
Diagnostic Workup
Diagnostic Workup: ABI
Diagnostic Workup: ABI
▶ Initial screening test of PAD
▶ ≤ 0.9 : confirm the diagnosis of PAD
▶ Normal resting ABI, abnormal post-exercise ABI
: toe raise, standing flat-footed and raising the heels off the
ground repeatedly, or post treadmill
=> large vessel inflow disease of distal aorta or iliac artery
Diagnostic Workup: ABI
PAD의 anatomic location과 significant stenosis의 여부 평가를
위해 다음으로 시행 할 imaging study는?
1) CT angiography
2) MR angiography
3) Conventional contrast angiography
Diagnostic Workup: Imaging Study
Diagnostic Workup: Imaging Study
Case 1: CT Angiography
이 환자의 시술이나 수술 전후로 시행할 치료 방침으로 적절한 것은?
1) Statin을 사용하여 LDLC를 70 mg/dL 이하로 낮춘다
2) 항고혈압제를 사용하여 혈압을 140/90 mmHg 이하로 유지한다
3) 항혈소판제로 aspirin이나 clopidogrel을 투여한다
4) 혈류 개선을 위해 oral vasodilator prostaglandins를 투여한다
5) Claudication 증상의 개선을 위해 cilostazol을 투여한다
Treatment of PAD
▶ Risk factor modification
▶ Exercise program
▶ Antiplatelet theraphy
▶ Revascularization
Treatment of PAD
▶ Target goal of LDLC
: Less than 100 mg/dL (I)
: Less than 70 mg/dL in very high risk patients (IIa)
▶ Very high risk in patients with established PAD
: Multiple major risk factors (especially, DM)
: Severe and poorly controlled risk factors (especially, smoking)
: Multiple risk factors of metabolic syndromes
: Individuals with acute coronary syndromes
CV Risk Reduction: Lipid Lowering Therapy
ACC/AHA guideline 2005. JACC 2006
▶ Target goal of BP (I)
: Less than 140/90 mmHg in nondiabetics
: Less than 130/80 mmHg in diabetics and chronic renal disease
▶ Beta adrenergic blocking agents (I)
: Not contraindicated in patients with PAD
: Do not adversely affect walking capacity
: Reduce the risk of MI and death in CAD
▶ ACE inhibitors (IIa)
: Reasonable for symptomatic patients with PAD
: To reduce the risk of adverse cardiovascular events
CV Risk Reduction: Antihypertensives
ACC/AHA guideline 2005. JACC 2006
▶ Control of DM
: Reduce the HgbA1C to less than 7% (IIa)
: To reduce microvascular complications
: Potentially improve CV outcomes
▶ Smoking cessation (I)
▶ Homocysteine lowering drugs (folic acid and Vitamin B12)
: Not well established (IIb)
: To reduce the risk of adverse cardiovascular events
ACC/AHA guideline 2005. JACC 2006
CV Risk Reduction: Others
ACC/AHA guideline 2005. JACC 2006
Claudication Management: Exercise Program
▶Warm-up and cool down period
of 5-10 min each
▶Types of exercise
: Treadmill and track walking
▶Intensity
: Set to a grade and speed that
elicits claudication symptoms
within 3 to 5 minutes
Claudication Management: Medications
Revascularization (Endovascular or Surgical)
Case 1: Percutaneous Transluminal Angioplasty
Case 1: Percutaneous Transluminal Angioplasty
▶ ABI within 1 week after PTA
▶ Re-evaluated at 3 month intervals for 1st year
: History, P/E, ABI
▶ Should be performed in the immediate post-PTA period at
intervals for at least 2 years
ACC/AHA guideline 2005. JACC 2006
CV Risk Reduction: Surveillance Program
이 환자의 향후 follow-up은 어떻게 하시겠습니까?
Post-stenting ABI
CC Left leg pain and color change
PH HT: medication for 8 years
SH Smoking : None
PI 1달 전부터 left leg pain 있어 인근 병원에서 치료했으나 호전
없었음. 1주전 신경외과에서 MRI상 HNP(L4-5)로 진단 후 수술 예정.
2일전부터 leg pain이 갑자기 심해지고 left foot에 skin color
change 및 ulcerative lesion 발생되어 전원
Case 2: 심 O O (66/F)
VS BP 140/90 mmHg PR 80/min
BT 36.4℃ RR 20/min
PE Color change, paresthesia, decreased sensation, and
ulcerative skin lesion on the left lower leg (more than ankle)
Right Left
Brachial & radial pulse Normal Normal
Femoral pulse Normal Normal
Popliteal pulse Normal Absent
Dorsalis pulse Normal Absent
Case 2: 심 O O (66/F)
CBC
WBC 14,700 /mm3
Hgb 14.9 g /dL
PLT 189 x 103 /mm3
LFT
AST 40 U/L
ALT 55 U/L
RFS and electrolytes
BUN 35.1 mg/dL
Cr 1.3 mg/dL
Na/K/Cl 132/3.5/97
Acute phase reactant
CRP 5.7 mg/dL
Lipid profiles
TC 139 mg/dL
TG 105 mg/dL
HDLC 39 mg/dL
LDLC 80 mg/dL
Glucose 210 mg/dL
HgbA1C 8.7%
Case 2: Laboratory Findings
병력상 이 환자에서 가장 의심되는 질환은?
Acute limb ischemia (ALI)
Case 2: 심 O O (66/F)
이 환자의 ALI의 심한 정도 (clinical categories)는?
1) Viable
2) Threatened marginally
3) Threatened immediately
4) Irreversible
Acute Limb Ischemia: Clinical Categories
ACC/AHA guideline 2005. JACC 2006
이 환자의 치료 방침을 결정하기 위해 고려해야 할 사항은?
1) Site and extent of occlusion
2) Embolus versus thrombus
3) Duration of ischemia
4) Patient co-morbidities
5) Contraindications to thrombolysis or surgery
Case 2: 심 O O (66/F)
Case 2: Percutaneous Transluminal Angioplasty
Case 2: FU Angiography after 3 Days
▶ Initial assessment : ABI
▶ Imaging study (duplex US, CTA, MRA, DSA)
▶ Risk factor assessment and modification
: Smoking cessation, dietary adjustment, lipid, BP, and glucose control
▶ Exercise program
▶ Anti-platelet therapy: aspirin or clopidogrel
▶ Cilostazol
▶ Revascularization (endovascular or surgical)
▶ Regular follow-up
Summary (I): Chronic PAD
Summary (II): Acute Limb Ischemia
Rapid or sudden decrease in limb perfusion
Threatens tissue viability
History and physical examination
Determine time of onset of symptoms
Emergent assessment of severity of ischemia:
Loss of pulses
Loss of motor and sensory function
Vascular lab assessment
ABI, TBI
Duplex ultrasound
Summary (II): Acute Limb Ischemia
ABI, TBI, or duplex ultrasound
No or minimal PAD Severe PAD documented
: ABI less than 0.4
: Flat PVR waveform
: Absent pedal flowConsider
: Atheroembolism
: Thromboembolism
: Phlegmasia cerulia dolens
Evaluation of source
: ECG or Holter
: TTE or TEE
: Abdominal US, MRA, or CTA
Treatment of ALI
: Immediate anticoagulation
: Assess etiology and severity
: Revascularization (thrombolysis,
endovascular, or surgical)